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A 2.5 kb clone containing the full-length coding sequence of a type-2A protein phosphatase catalytic subunit 
has been isolated from a rabbit skeletal muscle cDNA library constructed in IgtlO. The sequence of the 
protein deduced from the cDNA contains 309 residues (35.58 kDa). A major mRNA species at 2.0 kb and 
a minor component at 2.8 kb were visualized by Northern blotting in both skeletal muscle and liver. The 
type-2A enzyme showed weak homology with mammalian alkaline phosphatases between residues 55 and 
95. The protein sequence of the type-2A phosphatase from rabbit skeletal muscle differs from that reported 
for the bovine adrenal enzyme in three regions. 
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1. INTRODUCTION 
Four principal types of protein phosphatase 
catalytic subunit have been identified in the cytosol 
of mammalian cells which are responsible for 
dephosphorylating phosphoseryl and phospho- 
threonyl residues in proteins [l-3]. Other protein 
phosphatases exist, but are either located in 
mitochondria [4] or dephosphorylate tyrosine, 
rather than serine or threonine residues [5]. The 
four cytosolic serine/threonine-specific protein 
phosphatases have been subdivided into two 
classes, type-l and type-2, depending on whether 
they dephosphorylate the P-subunit of phos- 
phorylase kinase and are inhibited by two ther- 
mostable proteins inhibitor-l and inhibitor-2 
(type-l protein phosphatases) or whether they 
dephosphorylate the a-subunit of phosphorylase 
kinase and are insensitive to inhibitors-l and -2 
(protein phosphatases 2A, 2B and 2C) [l-3]. 
Correspondence address: P.T.W. Cohen, Department 
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However, it is now clear that the structure, 
substrate specificity and regulation of the three 
type-2 protein phosphatases are distinct. For ex- 
ample, protein phosphatase 2A is active in the 
absence of divalent cations, whereas protein 
phosphatases 2B and 2C have an absolute require- 
ment for Ca’+ and Mg’+, respectively. 
Protein phosphatases 1, 2A and 2C have broad 
and overlapping substrate specificities and account 
for nearly all the phosphatase activity in skeletal 
muscle and liver extracts towards a variety of en- 
zymes that regulate the major biodegradative and 
biosynthetic pathways in these tissues (review [l]). 
However, the phosphatases are present at similar 
concentrations in other tissues such as brain, where 
the protein substrates present in skeletal muscle 
and liver do not exist [6]. It is therefore likely that 
these phosphatases play even wider roles. For ex- 
ample, in brain they may regulate the phosphoryla- 
tion states of proteins that control neuro- 
transmitter synthesis and release. It is also 
established that the free catalytic units of protein 
phosphatases 1,2A and 2B do not exist in vivo, but 
are complexed to other subunits that either have a 
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regulatory function or target the phosphatases to 
distinct subcellular locations (review [ 11). 
In order to elucidate the structural relationships 
between each protein phosphatase catalytic 
subunit, and to facilitate identification of the 
regions which interact with regulatory macro- 
molecules, we have undertaken the cDNA cloning 
of the catalytic subunits of these enzymes. In this 
paper, we present the first phase of this study, 
namely the isolation of a clone containing the en- 
tire coding region of the catalytic subunit of a 
type-2A protein phosphatase and the determina- 
tion of its sequence. A preliminary account of part 
of this work was presented at the 1st International 
Conference on Post-Translational Modifications 
and Ageing in May 1987 [7]. 
2. MATERIALS AND METHODS 
2.1. Isolation and sequence analysis of peptides 
The free catalytic subunit of protein 
phosphatase 2A was purified as in [8,9] and 0.5 mg 
aliquots precipitated by addition of 0.1 vol. of 
100% (w/v) trichloroacetic acid. Following cen- 
trifugation for 5 min at 13 000 x g, the supernatant 
was discarded and the ‘precipitate washed twice 
with ether to remove trichloroacetic acid. Aliquots 
were then either redissolved in 0.1 ml of 50% 
(w/v) formic acid and incubated with a crystal of 
CNBr for 20 h at 4”C, or resuspended in 0.1 M 
NI-L+HC03 and digested for 20 h at 37°C with 
0.02 mg trypsin. The digests were dried, redis- 
solved in 1 ml of 0.1% (v/v) trifluoroacetic acid 
and chromatographed on a Vydac Cl8 column as in 
[lo]. Peptides were then analysed on a Beckman 
890C sequencer [lo] to determine their primary 
structures (table 1). 
2.2. Synthesis of oligonucleotides 
Oligonucleotides complementary to two pep- 
tides synthesized by Dr Gerald Zon, Center for 
Drug and Biologies, Division of Biochemistry and 
Biophysics, Bethesda, MD) were constructed on 
the basis of most frequent codon usage [II], with 
the use of GT pairing [12] or insertion of inosine 
and cytosine [13] in the third position of certain 
codons (table 2). 
2.3. Screening of the cDNA library and 
identification of positive clones 
A rabbit skeletal muscle cDNA library con- 
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strutted in hgtl0 [14] was screened without 
amplification on duplicate filters using [Y-~~P]ATP 
5 ’ -end-labelled oligonucleotides. Putative positive 
clones were plaque purified and their DNA 
isolated from plate lysates by formamide extrac- 
tion following caesium chloride density gradient 
purification of the phage [ 151. 
2.4. Subcloning and sequencing of the cDNA 
insert 
Phage DNA was digested with EcoRI, extracted 
with phenol and used without further purification 
for ligation of the insert into the EcoRI site of 
Bluescript pKS-M13+ [16]. Following transforma- 
tion of Escherichia coli JM109, recombinant 
plasmid DNA was purified by caesium chloride 
density gradient centrifugation, after alkaline lysis 
of the cells [17]. 
A set of ‘nested’ deletions was produced using 
exonuclease III and mung bean nuclease [16]. 
DNA from the plasmids containing the deletions 
was prepared as above, or by a rapid ‘small-scale’ 
boiling method [ 181. DNA sequencing was per- 
formed directly on the double-stranded, supercoil- 
ed plasmid DNA [19], using the dideoxy chain 
termination procedure [20], [cu-35S]dATPaS and 
buffer gradient gels [21]. Gaps and ambiguities 
were clarified by removing restriction fragments 
and sequencing the religated, truncated recombi- 
nant, or by using synthetic oligonucleotides as se- 
quencing primers. 
2.5. Northern blot analysis 
Poly(A)+ RNA was prepared from rabbit 
skeletal muscle and rabbit liver as described in 
[ 141, and blotting according to [ 171. The probe was 
the full-length cDNA insert in Bluescript and was 
labelled by nick-translation [ 171. 
3. RESULTS 
3.1. Screening of the cDNA library 
Screening of 1.2 x lo5 recombinants yielded two 
clones that were positive with the 36-base 
oligonucleotide and five that were positive with the 
38-base oligonucleotide (table 2). However, no 
clones were positive with both oligonucleotides. 
Restriction digests howed the cDNA insert sizes to 
range from 2.3 to 2.7 kb, sufficient to contain the 
entire coding region. Since the 36-base 
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Table 1 
Amino acid sequences of cyanogen bromide (CB) and tryptic (T) peptides isolated from 
the catalytic subunit of protein phosphatase 2A 
Peptide Sequence Position in 
sequence 
CBl ELFRI GGKSPDTNY 67- 80 
CB2 ELDDTLKYSFLQFDPAPRXG 277-296 
Al PAPRRGEP 291-298 
Tl ELDQWI EQLNECK 9- 21 
T2 GAGYTFGQDI SETFNXANGLTLVS 215-238 
T3 YSFLQFDPAPR 284-294 
T4 TPDYF 304308 
The peptide Al was generated by cleavage of an Asp-Pro bond, as described in the text. 
X denotes residues that could not be positively identified 
oligonucleotide was constructed from a peptide 
whose sequence lacked amino acids with high 
codon degeneracy, such as serine, the two positives 
with this oligonucleotide were investigated first. 
One positive clone had an internal EcoRI site, but 
had lost one of the terminal EcoRI sites. Thus 
digestion with EcoRI yielded a 600 base pair insert, 
the rest of the insert remaining attached to the 
AgtlO arms. The second positive clone had a 2.5 kb 
insert with no internal EcoRI site, and was 
therefore subcloned into Bluescript for sequence 
investigation. 
3.2. DNA sequence analysis 
DNA from each deletion of the 2.5 kb insert in 
Bluescript was electrophoresed and blotted onto 
nitrocellulose. Hybridisation revealed that the 
oligonucleotide-binding site was present in most of 
5’ 
the clones, but absent from those with the largest 
deletions. The smallest clone that hybridised to the 
oligonucleotide was therefore sequenced and 
shown to contain a cDNA sequence that encoded 
peptide Tl (table 2). The entire cDNA insert was 
subsequently sequenced and the results are shown 
in figs 1 and 2. 
The cDNA clone is 2557 base pairs, and it has 
894 base pairs of 5 ‘-non-coding region, an ATG 
codon at the start of an open reading frame of 927 
base pairs, and 736 base pairs of 3 ‘-non-coding 
region. The coding region is terminated by two 
consecutive stop codons. At position 2480 there is 
the AATAAA signal for cleavage of the messenger 
RNA and addition of the poly(A)+ tail. The 
molecular mass of the protein calculated from the 
sequence is 35582 Da. 
The peptide sequences determined by primary 
Xhol Xbal Sph I 3’ 
1 I . I 
0 0.5 1 .o 1.5 2.0 2.5 
Fig. 1. Restriction endonuclease map and strategy used to sequence the cDNA clone. The scale indicates the nucleotide 
position in kilobases from the 5 ‘-end of the cDNA insert. The arrows indicate the direction and length of the DNA 
sequences determined. Sequences were initiated with Bluescript primers for the nested deletions (a), Bluescript primers 
for the restriction fragments (0), and specific oligonucleotide primers (M). 
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GRCCRGTGGRTCGRGCRGCTGRRCGRGTGC 
DQUIEQLNEC 
RRGCAGCTGTCCGRGTCCCAGTCRRGRGC 
KQLSESQUKS - 
CCRGTTRCTGTCTGTGGRGRTGTGCRTGGG 
PUTUCGDUHG 
CTCTGCGRGRRGGCTRFG~RTCCTGRCR 
LCEKAKEILT 
1014 
40 
RRRGlWTCCRRCGTGCRRGRGGTTCGRTGT 
KESNUQEURC 
CRRTTTCRCGRTCTCRTGGFTGTTTRGR 
QFHDLHELFR 
1104 
70 
ATTGGTGGCRRRTCRCCRGRCRCRMTTRC TTGTTTRTGGGRGRTTRTGTTGRCRGRGGR TRTTACTCCGTTGWIRCRGTTRCRCTGCTT 1194 
IGGKSPDTNY LFIIGDYUDRG YYSUETUTLL 100 
GTRGCTCTTRRGGTTCGTTRCCGC RTCRCCRTTCTTCGFIGGTCRTGRGRGC RGRCRGRTCRCRCRGGlTTRTGGTTTCTRT 1284 
URLKURYRER ITILRGNHES RQITQUVGFY 130 
GATGfWTGTTTRRGRRRRTRTGGRfWCGCR RRTGTTTGGRRRTRTTTTRCGRTCTTTTT GRCTRTCTTCCTCTCACTGCCTTGGTGGRT 1374 
DECLRKYGNR NUUKVFTDLF DVLPLTRLUD 160 
GGGCRGRTCTTCTGTCTGCRCGGGGGCCTC 
GQIFCLHGGL’ 
TCRCCRTCTRTRGRTRCRCTGGRTCRCRTC 
SPSIDTLDHI 
TCRGRTCCRGRTGRCCGTGGTGGTTGGGGT 
SDPDDRGGUG 
RGRGCRCTTGRCCGCTTRCAGRRGTTCCC 
RRLDRLQEUP 
RTTTCTCCTCGRGGRGCTGGTTRCRCCTTT 
ISPRGAGYTF 
1464 
190 
1554 
220 
1644 
250 
1734 
280 
1824 
309 
1918 
2012 
2106 
2200 
2294 
2388 
2482 
2557 
CRTGRGGGTCCMITGTGTGRCTTGCTGTGG 
HEGPHCDLLU 
GGGCRRGRTRTTTCTGRGACATTCAATCAT 
GQDISETFNH 
TGCCRTGRCCGfWRTGTRGTfWCfWTTTTC 
CHDRNUUTIF 
RCTCTRRRRTRCTCTTTCTTGCRGTTTGRC 
TLKYSFLQFD 
GCCARTGGCCTGRCGTTGGTGTCTRGRGCT 
RNGLTLUSRR 
RGTGCTCCRRRCTRTTGTTRCCGCTGTGGT 
SRPNYCVRCG 
CCRGCTCCTCGTRGRGGCGRGCCRCRTGTT 
PRPRRGEPHU 
CGRRCACGGTGCTGGRGCGCGTGGRGGGGGCCCAGCAGCTGTTC 
TTCCAGCTCTGAGTCCTGGAFITGCGFlCGGCTTCAGAAGCR 
CTCCCTCCTGCCCFWiTCCCTCTCTCCCTCCCTCGCAGGC 
TCTCACTGTCTTGGRGCTGTCTGCGCCGGCGCCGAGCGACGTGTGCGTGTGG 
RTGGRCGRGMGGTGTTCCCRRGGRGCTG 
HDEKUFTKEL 
CRCCRGCTGGTGRTGGRGGGRTRTR~TGG 
HQLUHEGVNU 
RRCCRRGCTGCRRTCATGGRRCTTGRTGRC 
NQRRIHELDD 
RCTCGTCGTRCCCCRGRCTRCTTCCTGTRR 
TRRTPDYFL: 
80 
174 
258 
362 
456 
550 
644 
738 
832 
924 
10 
Fig.2. The cDNA and translated protein sequence of the type-2A protein phosphatase catalytic subunit from rabbit 
skeletal muscle. Information obtained by amino acid sequencing and the consensus sequence for addition of the 
poly(A)+ tail are underlined. 
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Table 2 
Oligonucleotides used to screen the cDNA library 
(1) Peptide Tl 
mRNA 
Oligo 
nucleotide 
(36 bases) 
(2) Peptide CB2 
mRNA 
Oligo- 
nucleotide 
(38 bases) 
E L D Q W I E Q L N E C K 
5’ GAA CUN GAU CAA UGG AUA GAA CAA CUN AAU GAA UGU AAA 3’ 
G UUA C G U G G UUA C G C G 
G C G 
3’ CTT GAG CTG GTT ACC TAG CTT GTT GAG TTG CTT ACG 5’ 
C C 
E L D D T L K Y S I? L Q F D P 
5’ GAA CUN GAU GAU ACN CUN AAA UAU UCN UUU CUN CAA UUU GAU CCN 3’ 
G UUA C C UUA G C AGU C UUA G C C 
G G C G 
3’ CTG CTG TGI GAG TTT ATG TCG AAG GAG GTT AAG CTG GG 5’ 
c c C 
N indicates that any of the four bases can be present 
structure analysis (table 1) were all found in the 
cDNA sequence (fig.2), establishing that the clone 
encodes a type-2A protein phosphatase catalytic 
subunit. The peptides isolated from tryptic digests 
were preceded by either lysine or arginine, and the 
CNBr peptides by methionine, apart from the pep- 
tide Al with the N-terminal sequence PAPRRGEP 
(table ‘1), which was generated by acid cleavage of 
an Asp-Pro bond. 
3.3. Northern blot analysis 
Analysis of poly(A)+ RNA from rabbit skeletal 
muscle and rabbit liver by Northern blotting show- 
ed that the protein phosphatase 2A clone recog- 
nized a major mRNA species at 2.0 kb and a minor 
band at 2.8 kb in both muscle and liver (fig.3). In 
addition, a minor 1.3 kb band was also evident. 
4. DISCUSSION 
The molecular mass of the type-2A catalytic 
subunit deduced from the cDNA (35.58 kDa) is in 
very close agreement with the apparent molecular 
mass of 36 kDa estimated by SDS-polyacrylamide 
gel electrophoresis [22]. In the proposed sequence, 
the initiator methionine is followed by an aspartyl 
residue and it has been noted that such Met-Asp 
bonds are not cleaved after synthesis [23]. Since 
Fig.3. Northern blot of 5 ,ug poly(A)+ RNA from muscle 
(M) and liver (L). The probe used was the full-length 
cDNA clone and the final wash was 0.2 x SSC at 65°C 
for 15 min (1 x SSC: 0.15 M NaCl, 0.015 M sodium 
citrate, pH 7). The positions of the 28 S and 18 S 
ribosomal RNAs and the origin are indicated. 
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32 40 
CEKAKEIL T 
TGCGAGAAGGCTAAAGAAATCCTG-ACA - 
TGC-AGAAGGCTAAAGAAATCCTGGACA - 
C RRLKKSWT 
291 309 
PAPRRGEPHVTRRTPDYFL:: 
CCAGCTCCTCGTAGAGGCGAGCCACATGTTACTCGTCGTACCCCAGACTACTTCCTGTAATGA - - - 
CCAGCACC-CGCAGAGGCGAGCCACATGTTACTCGTCGTACCCCAGACTACTTCCTGTAATGAA 
P A P AEASHMLLVVPQTTSCNE 
Fig.4. Comparison of protein and cDNA sequences of rabbit skeletal muscle (this paper) and’bovine adrenal [27] 
type-2A protein phosphatases from residues 32-40 and 292-309. The differences between the sequences are underlined. 
FHDLHELFRIGGKSPDTN 
LHHNIRDIDUIHGGGRK- 
-DIDUILGGGRK- 
-DIDUILGGGRK- 
QLLNRR -RDUTLGGGAK--T Q G K T 224 
Fig.5. Homology between protein phosphatase 2A (2A) and alkaline phosphatases from human liver (L), placenta (P), 
intestine (I) and E. coli (E). Identities are boxed, and the number of the last amino acid in each sequence is given. 
the N-terminus of the protein is blocked (un- 
published) the initiator methionine is most likely to 
be acetylated. In this case, the molecular mass 
would be 35623 Da. 
An unexpected finding was that the cDNA clone 
was 2.5 kb, whereas the major mRNA detected by 
Northern blotting was only 2.0 kb. However, since 
a minor mRNA band is present at 2.8 kb (fig.3), it 
is possible that this is the species which has been 
cloned. Alternatively, some of the 5 ‘-end may be 
a cloning artefact. 
A feature of the DNA coding for skeletal muscle 
proteins is their high GC content. This is striking 
in the coding regions, particularly in the third 
codon position where G or C is found 80-90% of 
the time [14,24]. In contrast, the cDNAs of liver 
proteins have about 50% G or C in the third codon 
position [24]. It is therefore of interest that the 
coding region of protein phosphatase 2A from rab- 
bit skeletal muscle only contains 45% G or C in the 
third codon position, suggesting that it might not 
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be a muscle-specific protein. This conclusion was 
supported by Northern blotting experiments which 
showed that the muscle cDNA clone hybridised 
equally efficiently to liver and muscle mRNA, 
yielding bands of identical sizes (fig.3). If protein 
phosphatase 2A is the same gene product in muscle 
and liver, this would be similar to protein 
phosphatase 2C, where the same two isoforms (2Cr 
and 2Cz) are found in both skeletal muscle and 
liver, as judged by peptide mapping [25]. 
While this paper was in preparation we received 
a preprint of the work of Mumby and co-workers 
[26] who have isolated and sequenced cDNA 
coding for a type-2A catalytic subunit from bovine 
adrenal cortex. Their sequence differs from the 
rabbit skeletal muscle protein in three regions. 
Firstly, there is a single amino acid change at 
residue 55, which is cysteine in the skeletal muscle 
sequence and arginine in the bovine adrenal pro- 
tein, resulting from a single base change. Secondly, 
the sequence from residue 32 to 40 is completely 
Volume 221, number 2 FEBS LETTERS September 1987 
different (fig.4). Thirdly, the bovine adrenal se- 
quence is completely different from residue 294 
and has 16 additional residues at the C-terminus, 
terminating at residue 325. However, inspection of 
nucleotide sequences shows that the differences 
between residue 32 and 40 are explained by the 
absence of a single G in the bovine adrenal se- 
quence at nucleotide residue 991 and insertion of a 
G after 1011 (fig.4). Similarly, at the C-terminus, 
the differences are explained by the presence of an 
additional T at nucleotide 1773 of the rabbit 
skeletal muscle cDNA clone (fig.4). It is unknown 
whether these discrepancies are explained by 
species differences or sequencing errors. However, 
the C-terminus of the skeletal muscle enzyme is 
correct, since three peptides (T3, T4 and CB2) cor- 
responding to this region have been sequenced 
(table 1). We are also confident that the nucleotide 
sequence encoding residues 32-40 is correct since 
the sequences of both cDNA strands agreed in this 
region. If the differences are explained by sequenc- 
ing errors, then there would only be a single amino 
acid difference between the rabbit skeletal muscle 
and bovine adrenal enzymes. 
There are 39 differences in the third codon posi- 
tion and a single difference in the first codon posi- 
tion between the rabbit skeletal muscle and bovine 
adrenal cDNAs that do not change the deduced 
amino acid sequence. There is a further single base 
change in the first codon position, that accounts 
for the single amino acid difference at residue 55, 
previously discussed. 
A short section of the type-2A protein 
phosphatase from skeletal muscle (residues 55-95) 
shows weak homology with the alkaline 
phosphatases from human placenta [27,28], liver 
[29] and intestine [30,31] (fig.5). The type-2A pro- 
tein phosphatase and all the mammalian alkaline 
phosphatases are identical at six sites. At a further 
two, the type-2A protein phosphatase is identical 
to the placental and intestinal alkaline 
phosphatases, while at three other sites it is iden- 
tical to the liver alkaline phosphatase. The overall 
identity between the type-2A protein phosphatase 
and alkaline phosphatases in this region is 27%. 
To obtain this homology it was necessary to in- 
troduce a single amino acid deletion in the se- 
quences of the alkaline phosphatases with respect 
to protein phosphatase 2A. However, this is at a 
position where E. coli alkaline phosphatase has 
already undergone a deletion compared to the 
mammalian alkaline phosphatases [32]. The metal 
ligand sites and residues that interact with 
phosphate are known for E. coli alkaline 
phosphatase, and do not lie in this section of the 
protein. It is therefore unclear whether the con- 
served amino acids are essential for the function of 
mammalian phosphatases or whether they merely 
reflect a distant evolutionary relationship. 
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